Form 8-K - Current report:
SEC Accession No. 0001520138-25-000190
Filing Date
2025-06-27
Accepted
2025-06-27 17:20:28
Documents
12
Period of Report
2025-06-26
Items
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20250626_8k.htm   iXBRL 8-K 25412
  Complete submission text file 0001520138-25-000190.txt   189378

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bivi-20250626.xsd EX-101.SCH 3026
3 XBRL LABEL FILE bivi-20250626_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE bivi-20250626_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20250626_8k_htm.xml XML 3568
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 251087962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)